Overview A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients Status: Withdrawn Trial end date: 2010-04-01 Target enrollment: Participant gender: Summary The present study is designed to collect data on real world experience on use of Medrol in acute asthma in Indian patients. Details Lead Sponsor: PfizerTreatments: MethylprednisoloneMethylprednisolone AcetateMethylprednisolone HemisuccinatePrednisolonePrednisolone acetatePrednisolone hemisuccinatePrednisolone phosphate